logoTry Persana

Phil, Inc. - Company Overview, Founder, CEO, Funding & Investment Details

Complete information about Phil, Inc. including founder details, CEO information, total funding raised, headquarters location, team size, and recent investment rounds.

Phil, Inc. company logo

Medication Access, Simplified.

Phil, Inc. helps pharmaceutical brands improve patient access, provider engagement, and brand outcomes through innovative technology and dedicated support.

HeadquartersSan Francisco, United States
Team size201-500
Founded2015

What is Phil, Inc.? - Company Overview & Details

Phil, Inc. is Phil, Inc. helps pharmaceutical brands improve patient access, provider engagement, and brand outcomes through innovative technology and dedicated support. Founded in 2015, the company is headquartered in San Francisco, United States.

Who Founded Phil, Inc.?

Phil, Inc. was founded by Deepak Thomas.

Who are the Key Executives at Phil, Inc.? - Leadership Team

Phil, Inc. is led by experienced executives in key positions:

Phil, Inc. Company Details & Key Information

Where is Phil, Inc. located?

Phil, Inc. is headquartered in San Francisco, United States.

How many employees does Phil, Inc. have?

Phil, Inc. has 201-500 employees.

When was Phil, Inc. founded?

Phil, Inc. was founded in 2015.

How much funding has Phil, Inc. raised?

Phil, Inc. has raised $60 million across 10 funding rounds. The most recent funding was completed on 2025-08-08.

Funding Overview

Phil, Inc. has raised a total of $60 million in growth debt financing from K2 HealthVentures to enhance technology integration and continue customer expansion.

$60 million
Total Funding Raised
10
Funding Rounds
2025-08-08
Latest Round

Phil, Inc. Funding History

Debt financing
2025-08-08
$60 million
Series D
2021-12-17
$56 million

Who are the key investors in Phil, Inc.?

Phil, Inc. is backed by 2 key investors including K2 HealthVentures, Warburg Pincus. These investors focus on Healthcare, Life Sciences, Growth Equity sectors.

Phil, Inc. Investor Overview

2
Key Investors
3
Focus Areas
0
Notable Investments

Complete List of Phil, Inc. Investors

K2 HealthVentures

A healthcare and life sciences-focused investment firm.

Investment Focus
Healthcare
Life Sciences

Warburg Pincus

A leading global growth investor.

Investment Focus
Growth Equity
Healthcare

What sectors do Phil, Inc. investors focus on?

The investors backing Phil, Inc. primarily focus on Healthcare, Life Sciences, Growth Equity sectors.

Healthcare
Life Sciences
Growth Equity

Featured Investor: K2 HealthVentures

K2 HealthVentures

A healthcare and life sciences-focused investment firm.

Notable Investments:

What are Phil, Inc.'s future plans?

Phil, Inc. Phil, Inc. aims to redefine digital access and enhance patient care using AI technology.

Phil, Inc. Strategic Outlook

Strategic Focus
Defined
2
Key Challenges
2
Growth Opportunities

What challenges does Phil, Inc. face?

Phil, Inc. has identified 2 key challenges that need to be addressed for continued growth and success.

Key Challenges for Phil, Inc.

1

Access barriers to medications

2

High costs of traditional hubs

What opportunities does Phil, Inc. have?

Phil, Inc. has identified 2 key opportunities for growth and market expansion.

Growth Opportunities for Phil, Inc.

1

Expansion into new healthcare markets

2

Integration of AI technology

Phil, Inc. Strategic Position Summary

Key Focus Areas

Phil, Inc. is addressing 2 strategic challenges to strengthen its market position.

Growth Potential

The company has identified 2 key opportunities for expansion and growth.

What are the latest news about Phil, Inc.?

Phil, Inc. has 2 recent news updates covering key business developments and market activities.

Phil, Inc. News Overview

2
Recent Articles
Active
Media Coverage
2025-07-14
Latest Update

What is Phil, Inc. in the news for?

Phil, Inc. is currently featured in news for Phil Inc. received financing of $60M in growth debt financing. and other significant business developments.

Recent News Articles About Phil, Inc.

Article 1
2025-07-14

Phil Inc. received financing of $60M in growth debt financing.

Phil received $60 million growth debt financing from K2 HealthVentures to enhance technology and customer expansion.

svdaily.com
Read News
Article 2
2023-07-06

Phil Inc. partnered with RedHill Biopharma Ltd. on Jul 6th '23.

Phil partners with RedHill Biopharma to make Talicia® available via the PhilRx Patient Access Platform.

businesswire.com
Read News

Phil, Inc. FAQ - Frequently Asked Questions About Founder, CEO, Funding & Company Details

Find answers to the most common questions about Phil, Inc. including information about founders, CEO, funding history, investors, headquarters location, and company details. 15 frequently asked questions covering key information about the company.

Phil, Inc. Questions & Answers - Company Information

Q1

What is Phil, Inc.?

Phil, Inc. helps pharmaceutical brands improve patient access, provider engagement, and brand outcomes through innovative technology and dedicated support.

Q2

Who founded Phil, Inc.?

Phil, Inc. was founded by Deepak Thomas.

Q3

How much funding has Phil, Inc. raised?

Phil, Inc. has raised a total of $$60 million across 10 funding rounds. The most recent funding was completed on 2025-08-08.

Q4

Who are the investors in Phil, Inc.?

Phil, Inc.'s key investors include K2 HealthVentures, Warburg Pincus.

Q5

Where is Phil, Inc. headquartered?

Phil, Inc. is headquartered in San Francisco, United States.

Q6

When was Phil, Inc. founded?

Phil, Inc. was founded in 2015.

Q7

How many employees does Phil, Inc. have?

Phil, Inc. has 201-500 employees.

Q8

What was Phil, Inc.'s latest funding round?

Phil, Inc.'s latest funding round was a Debt financing round of $$60 million completed on 2025-08-08.

Q9

What does the company do?

Phil, Inc. helps pharmaceutical brands improve patient access, provider engagement, and brand outcomes through innovative technology.

Q10

How much funding?

$60 million

Q11

Latest funding date?

2025-08-08

Q12

Who are the investors?

K2 HealthVentures Warburg Pincus

Q13

What are the challenges?

Access barriers to medications High costs of traditional hubs

Q14

What are the opportunities?

Expansion into new healthcare markets Integration of AI technology

Q15

Latest news?

Phil received $60 million growth debt financing from K2 HealthVentures to enhance technology and customer expansion. Phil partners with RedHill Biopharma to make Talicia® available via the PhilRx Patient Access Platform.

More Information About Phil, Inc.

For additional details about Phil, Inc., including the latest news, funding updates, and company developments, explore our comprehensive company database. Find information about startup funding, company valuations, executive leadership, and business intelligence data.